INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Grant or awardVerified data

Lillie Charisse R reported EXC

Director · EXELON CORP · Common stock- deferred stock units

Side
A
Value
$41K
Shares
940
Price
$43.87
Executed
Dec 31, 2025
Disclosed
Jan 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 31 executedJan 2, 2026 disclosed

EXC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+5 / 25

$41K reported value · 8.8% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · EXC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    A$36K
    897 sh
    Sep 30, 2026Oct 1, 2026
    traded Sep 30, 2026
    +1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    A$242
    6 sh
    Sep 30, 2026Oct 1, 2026
    traded Sep 30, 2026
    +1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    A$233
    5 sh
    Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    +1dSEC FORM 4

    Evidence

    21
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    A$36K
    778 sh
    Jun 30, 2026Jul 1, 2026
    traded Jun 30, 2026
    +1dSEC FORM 4

    Evidence

    9
    SK
    Segedi Bryan KDirector
    EXCEXELON CORP
    Grant or award
    A—
    3,720 sh
    Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    +1dSEC FORM 4

    Evidence

    9
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    A—
    3,720 sh
    Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    +1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    A—
    3,720 sh
    Apr 28, 2026Apr 29, 2026
    traded Apr 28, 2026
    +1dSEC FORM 4

    Evidence

    9
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    A$36K
    739 sh
    Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    +1dSEC FORM 4

    Evidence

    9
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    A$245
    5 sh
    Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    +1dSEC FORM 4

    Evidence

    13
    LR
    Lillie Charisse RDirector
    EXCEXELON CORP
    Grant or award
    A$44K
    878 sh
    Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    +1dSEC FORM 4

    Evidence

    13
    SK
    Segedi Bryan KDirector
    EXCEXELON CORP
    Grant or award
    A$44K
    878 sh
    Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    +1dSEC FORM 4

    Evidence

    13
    RC
    Rogers Matthew CDirector
    EXCEXELON CORP
    Grant or award
    A$44K
    878 sh
    Mar 31, 2026Apr 1, 2026
    traded Mar 31, 2026
    +1dSEC FORM 4

    Evidence

    21
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Option exercise
    M—
    2,110 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Grant or award
    A—
    5,673 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Grant or award
    A—
    7,019 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    9
    KA
    Kleczynski Robert ASVP, Controller & Tax
    EXCEXELON CORP
    Option exercise
    M—
    7,019 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    13
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    M—
    5,197 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    13
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    M—
    7,031 sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    17
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Option exercise
    M—
    24.7K sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    23
    JM
    Jones Jeanne MEVP, CFO, Audit & Risk
    EXCEXELON CORP
    Tax withholding
    F$705K
    16.1K sh
    Feb 2, 2026Feb 4, 2026
    traded Feb 2, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001972789-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 31, 2025
    Published
    Jan 2, 2026
    Ingested by INSIDER
    Nov 5, 04:24 UTC
    Last re-read
    Nov 5, 04:24 UTC

    Extracted facts

    Filer
    Lillie Charisse R
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    EXELON CORP
    Ticker
    EXC
    Shares
    940
    Price per share
    $43.87
    Value
    $41,238
    Execution date (reported)
    Dec 31, 2025
    Owned after transaction
    11.6K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 940
    • Price: $43.87

    = $41,238

    What this establishes

    Lillie Charisse R filed this Form 4 reporting a grant or award of EXC on Dec 31, 2025. It became public on Jan 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Lillie Charisse Rcik:0001972789
    Issuer
    EXELON CORPcik:0001109357

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.